Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Post by kooter33on Jan 24, 2018 12:34pm
142 Views
Post# 27424350

IMO,,, MMs were caught

IMO,,, MMs were caughtoffside on this trade.  Slow decent from recent highs indicates they are balancing the books.  BTW, CC-033 still buying more than selling.  ANON has joined TD in selling more than they are buying.  Lets see where this bottoms out and I am adding to my position.  Best is yet to come!

House Positions for C:PMN from 20180124 to 20180124
House Bought $Val Ave Sold $Val Ave Net $Net
36 Latimer 205,759 88,009 0.428 1,348 630 0.467 204,411 -87,379
33 Canaccord 244,887 110,571 0.452 132,676 57,698 0.435 112,211 -52,873
2 RBC 155,485 68,622 0.441 76,741 34,249 0.446 78,744 -34,373
99 Jitney 257,867 112,081 0.435 215,574 94,328 0.438 42,293 -17,753
58 Qtrade 35,000 15,050 0.43 0   35,000 -15,050
89 Raymond James 18,400 8,352 0.454 0   18,400 -8,352
143 Pershing 11,700 5,511 0.471 0   11,700 -5,511
79 CIBC 45,486 20,271 0.446 39,711 17,655 0.445 5,775 -2,616
83 Mackie 54,000 23,991 0.444 51,500 23,100 0.449 2,500 -891
9 BMO Nesbitt 85,050 37,480 0.441 83,394 37,026 0.444 1,656 -454
88 Credential 5,000 2,274 0.455 3,609 1,590 0.441 1,391 -684
22 Fidelity 1,000 425 0.425 0   1,000 -425
57 Interactive 500 232 0.464 1,000 445 0.445 -500 213
39 Merrill Lynch 1,000 445 0.445 5,000 2,210 0.442 -4,000 1,765
76 Industrial Alliance 0   5,000 2,274 0.455 -5,000 2,274
53 Morgan Stanley 1,000 480 0.48 9,000 3,960 0.44 -8,000 3,480
59 PI 0   15,500 7,440 0.48 -15,500 7,440
80 National Bank 8,000 3,590 0.449 28,850 12,751 0.442 -20,850 9,161
124 Questrade 31,159 13,690 0.439 55,075 24,193 0.439 -23,916 10,503
19 Desjardins 9,500 4,260 0.448 44,500 19,778 0.444 -35,000 15,518
85 Scotia 209,860 93,620 0.446 249,035 109,506 0.44 -39,175 15,886
13 Instinet 216,000 93,476 0.433 289,000 127,419 0.441 -73,000 33,943
7 TD Sec 274,956 122,716 0.446 417,456 183,423 0.439 -142,500 60,707
1 Anonymous 301,102 135,160 0.449 448,742 200,631 0.447 -147,640 65,471
TOTAL 2,172,711 960,306 0.442 2,172,711 960,306 0.442 0 0

Bullboard Posts